Medicare Enrolled
Dr. Earl Mangin, MD
Cardiovascular Disease · Houston, TX
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mangin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mangin? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mangin
Dr. Earl Mangin is a cardiovascular disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Mangin performed 10,556 Medicare services across 6,472 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mangin received a total of $23,979 from 42 pharmaceutical and/or device companies across 454 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mangin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in TX$ $23,979 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,556
Medicare services
Top 3% in TX for cardiovascular disease
6,472
Unique beneficiaries
$161
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~556 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test | 2,768 | $42 | $118 |
| Office visit, established patient (30-39 min) | 1,326 | $90 | $145 |
| Electrocardiogram (EKG), 12-lead | 1,049 | $10 | $125 |
| Echocardiogram, transthoracic | 906 | $130 | $1,400 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 709 | $51 | $575 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 653 | $616 | $1,972 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 599 | $1,055 | $3,245 |
| Hospital follow-up visit, moderate complexity | 393 | $61 | $150 |
| Remote pacemaker monitoring, 90 days | 348 | $23 | $94 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 243 | $20 | $110 |
| Ultrasound of both sides of head and neck blood flow | 217 | $141 | $657 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 180 | $19 | $125 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 155 | $39 | $110 |
| Initial hospital admission, high complexity | 125 | $135 | $300 |
| New patient office visit, complex (60-74 min) | 94 | $149 | $476 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 88 | $9 | $40 |
| Office visit, established patient, complex (40-54 min) | 76 | $126 | $215 |
| EKG interpretation and report | 71 | $5 | $40 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 66 | $187 | $670 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 54 | $139 | $504 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 52 | $26 | $168 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 48 | $336 | $2,115 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 48 | $70 | $490 |
| Cardiac catheterization | 45 | $188 | $1,500 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 38 | $48 | $167 |
| Evaluation of cardiac rhythm monitor system | 36 | $35 | $105 |
| Complete ultrasound study of arm and leg arteries | 35 | $69 | $650 |
| Ultrasound of leg arteries or artery grafts | 34 | $182 | $800 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 33 | $1,937 | $6,098 |
| Programming of dual lead pacemaker system | 20 | $58 | $166 |
| Coronary stent placement | 18 | $372 | $3,500 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $18 | $65 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 14 | $652 | $2,345 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.0% high complexity
42.6% medium
42.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,979
Total received (2018-2024)
Avg $3,426/year across 7 years
Top 17% in TX for cardiovascular disease
42
Companies
454
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,960 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,328
2023$2,315
2022$2,953
2021$3,618
2020$1,166
2019$5,066
2018$6,533
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$6,823
Edwards Lifesciences Corporation
$3,930
Medtronic, Inc.
$3,839
BOSTON SCIENTIFIC CORPORATION
$1,971
Abbott Laboratories
$1,793
Janssen Pharmaceuticals, Inc
$682
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$444
E.R. Squibb & Sons, L.L.C.
$390
PFIZER INC.
$380
ABIOMED
$375
Boston Scientific Corporation
$372
Shockwave Medical, Inc
$337
AstraZeneca Pharmaceuticals LP
$322
Amgen Inc.
$293
SANOFI-AVENTIS U.S. LLC
$222
Boehringer Ingelheim Pharmaceuticals, Inc.
$157
GE HealthCare
$148
Elutia, Inc.
$141
Acutus Medical, Inc.
$135
Novartis Pharmaceuticals Corporation
$125
Tactile Systems Technology Inc
$112
Cardiovascular Systems Inc.
$107
Impulse Dynamics (USA) Inc.
$104
Regeneron Healthcare Solutions, Inc.
$101
Merck Sharp & Dohme LLC
$93
iRhythm Technologies, Inc.
$85
Preventice Services, LLC
$55
HeartFlow, Inc.
$50
G Medical Diagnostic Services, Inc.
$49
Kowa Pharmaceuticals America, Inc.
$48
AltaThera Pharmaceuticals LLC
$46
Novo Nordisk Inc
$45
Esperion Therapeutics, Inc.
$37
Gilead Sciences, Inc.
$30
Astellas Pharma US Inc
$24
BIOTRONIK INC.
$19
Amarin Pharma Inc.
$19
Philips Electronics North America Corporation
$18
Biosense Webster, Inc.
$16
Teleflex LLC
$15
Aziyo Biologics, Inc.
$15
ConvaTec Inc.
$13
Top 3 companies account for 60.9% of total payments
Associated products mentioned in payments ›
ACCOLADE SR · AQUACEL AG+ EXTRA · AZURE XT DR MRI SURESCAN · Advisa · Allia · Assurity Pacemaker · Azure · BG Mini Plus · BRILINTA · CARDIOMEMS · CARTO 3 · CHANTIX · CONFIRM RX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink · CareLink Express · Circulatory Support · Confirm Rx · CoreValve Evolut · Coronary Orbital Atherectomy System · ECM Patch · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLEXITOUCH · Flexitouch Plus · GUIDELINER · General - Therapies · HAWKONE · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · IGT D Peripheral · IN.PACT Admiral · INVOKANA · Impella · JARDIANCE · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MERLIN@HOME · MICRA · MITRACLIP · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · MitraClip System · NEXLETOL · ONYX FRONTIER · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Percepta · Peripheral Orbital Atherectomy System · Pouch · RESOLUTE ONYX · REVEAL LINQ · Repatha · Resolute · Reveal LINQ · SAPIEN 3 Ultra RESILIA · SELECTSECURE · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · Solara · Sotalol Hydrochloride · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN FLX · Wegovy · XARELTO · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $227 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
396
Per 100K population
8.3
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mangin is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 17%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mangin experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Mangin performed 2,768 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mangin receive payments from pharmaceutical companies?
Yes. Dr. Mangin received a total of $23,979 from 42 companies across 454 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mangin's costs compare to other cardiovascular diseases in Houston?
Dr. Mangin's average Medicare payment per service is $161. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mangin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Houston
Browse cardiovascular diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology